What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study
Objectives Early phase cell therapy trials face many barriers to successful, timely completion. To optimise the conduct of a planned clinical trial of mesenchymal stem cell (MSC) therapy for chronic stroke, we sought patient and physician views on possible barriers and enablers that may influence th...
Saved in:
| Main Authors: | Dean A Fergusson, Dar Dowlatshahi, Manoj M Lalu, Justin Presseau, Yuan Yi Dong, Gisell Castillo, Madison Foster, Analyssa Cardenas, Whitney Tam, Jennifer Zlepnig, Deborah Timpson, Pascale Juneau |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-03-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/3/e034354.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial
by: Dean A Fergusson, et al.
Published: (2021-03-01) -
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy
by: Dean A Fergusson, et al.
Published: (2021-08-01) -
Recurrence of cervical artery dissection: protocol for a systematic review
by: Dean A Fergusson, et al.
Published: (2020-09-01) -
Canadian Physicians’ Choices for Their Own Colon Cancer Screening
by: Mamoon Raza, et al.
Published: (2006-01-01) -
Prevalence of non-contrast CT abnormalities in adults with reversible cerebral vasoconstriction syndrome: protocol for a systematic review and meta-analysis
by: Dean A Fergusson, et al.
Published: (2020-09-01)